高级检索
当前位置: 首页 > 详情页

Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

机构: [1]Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China [2]Beijing Tongren Hosp, Dept Neurol, Beijing 100730, Peoples R China [3]Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurol, Qingdao 266071, Shandong, Peoples R China
出处:
ISSN:

关键词: multiple sclerosis neuromyelitis optica myelin oligodendrocyte glycoprotein

摘要:
Background Whether antibody to myelin oligodendrocyte glycoprotein (MOO) can be a diagnostic marker for multiple sclerosis (MS) is still controversial. Recent studies suggested that serum specific anti-MOG epitope antibody might be an MS specific marker. However, these studies did not include neuromyelitis optica (NMO) which might be proven to also have anti-MOO antibody. Hence, the present study was undertaken to investigate the clinical value of serum antibodies to 25 MOG epitopes in conventional MS (CMS) and NMO. Methods Serum anti-MOO epitope IgG was detected in 61 CMS patients, 54 NMO patients, and 77 healthy controls, using enzyme-linked immunosorbent assay (ELISA). Results Anti-MOG(27-38) IgG levels in both CMS and NMO patients were significantly higher than that in healthy controls (optical density (OD): 0.64+/-0.38, 0.48+/-0.23 vs. 0.19+/-0.09; P=0.000). CMS and NMO patients in relapse stage had significantly higher anti-MOG(27-38) IgG level than patients in remission stage (OD: 0.55+/-0.14 vs. 0.24+/-0.09, P=0.027). Conclusion Although serum anti-MOO epitope IgG could not differentiate MS from NMO, it may be a useful marker for monitoring disease activity. Chin Med J 2012;125(18):3207-3210

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2010]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25477 今日访问量:1 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)